NCT01382030View on ClinicalTrials.gov

Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

September 30, 2010

Study Completion Date

January 31, 2011

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

EIA chemotherapy

ifosfamide 1500 mg/m² iv days 1 - 4, etoposide 125 mg/m² iv days 1 and 4, and adriamycin 50 mg/m² iv day 1

Trial Locations (1)

69120

Heidelberg University Clinics, Heidelberg

All Listed Sponsors
collaborator

German Cancer Research Center

OTHER

lead

Heidelberg University

OTHER

NCT01382030 - Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter